In Silico Coformer Screening for Mefenamic Acid Cocrystallization
DOI:
https://doi.org/10.31965/infokes.Vol22.Iss1.1375Keywords:
Cocrystal, Coformer, Screening, Molecular Docking, Mefenamic AcidAbstract
Cocrystallization is a widely used approach to enhance the solubility and dissolution characteristics of poorly soluble drugs. A pharmaceutical cocrystal is a multicomponent system composed of a solid active pharmaceutical ingredient (API) and a coformer, governed by non-covalent interactions. Screening for suitable coformers is essential to obtain an optimal cocrystal for specific drugs. This study aims to determine the drug-coformer interactions to select the most suitable coformer for cocrystal formation using the molecular docking method. Mefenamic acid, classified as a class II drug in the biopharmaceutical classification system (BCS), was used as the model drug. Two-dimensional structures of mefenamic acid (PubChem CID: 4044) and potential coformers were sourced from PubChem. Geometric optimization of all compounds was performed using GaussView 5.0.8 and Gaussian09 with the 3-21G basis set and Density Functional Theory (DFT) B3LYP method. The optimized compounds were prepared by adding hydrogen atoms and calculating Kollman partial charges using AutoDock 4.2. A grid box of size 40 Å × 40 Å × 40 Å was generated, with a maximum radius of 0.375 Å set as the surface distance in each simulation. A hundred conformations were run using the Lamarckian Genetic Algorithm. Interaction types and binding energies were analyzed using VMD 1.9.2 and BIOVIA Discovery Studio 2020 to compare interactions between mefenamic acid and each coformer. The results revealed that most coformer compounds formed interactions with mefenamic acid via hydrogen bonding and π–interactions. Saccharin demonstrated the most optimal interaction with mefenamic acid, with a binding free energy of –3.1 kcal/mol. Saccharin was identified as the most suitable coformer for mefenamic acid cocrystal formation based on the molecular docking study. Further experimental validation of saccharin is recommended to confirm its effectiveness in cocrystallization with mefenamic acid.
Downloads
References
Berry, D. J., & Steed, J. W. (2017). Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design. In Advanced Drug Delivery Reviews (Vol. 117, pp. 3–24). Elsevier B.V. https://doi.org/10.1016/j.addr.2017.03.003
Bhandaru, J. S., Malothu, N., & Akkinepally, R. R. (2015). Characterization and solubility studies of pharmaceutical cocrystals of eprosartan mesylate. Crystal Growth and Design, 15(3), 1173–1179. https://doi.org/10.1021/cg501532k
Bora, P., Saikia, B., & Sarma, B. (2018). Regulation of π···π Stacking Interactions in Small Molecule Cocrystals and/or Salts for Physiochemical Property Modulation. Crystal Growth and Design, 18(3), 1448–1458. https://doi.org/10.1021/acs.cgd.7b01377
Censi, R., & Di Martino, P. (2015). Polymorph impact on the bioavailability and stability of poorly soluble drugs. Molecules, 20(10), 18759–18776. https://doi.org/10.3390/molecules201018759
Cimolai, N. (2013). The potential and promise of mefenamic acid. In Expert Review of Clinical Pharmacology (Vol. 6, Issue 3, pp. 289–305). https://doi.org/10.1586/ecp.13.15
Gajjar, A., Savjani, J. K., Pathak, C. D., Savjani, K. T., Gajjar, A. K., & Savjani, J. K. (2013). Cocrystal formation of paracetamol with indomethacin and mefenamic acid: An efficient approach to enhance solubility. International Journal of Pharmacy and Pharmaceutical Sciences.
Grimme, S. (2008). Do special noncovalent π-π stacking interactions really exist? Angewandte Chemie - International Edition, 47(18), 3430–3434. https://doi.org/10.1002/anie.200705157
Karimi-Jafari, M., Padrela, L., Walker, G. M., & Croker, D. M. (2018). Creating cocrystals: A review of pharmaceutical cocrystal preparation routes and applications. In Crystal Growth and Design (Vol. 18, Issue 10, pp. 6370–6387). American Chemical Society. https://doi.org/10.1021/acs.cgd.8b00933
Khalaji, M., Potrzebowski, M. J., & Dudek, M. K. (2021). Virtual Cocrystal Screening Methods as Tools to Understand the Formation of Pharmaceutical Cocrystals - A Case Study of Linezolid, a Wide-Range Antibacterial Drug. Crystal Growth and Design, 21(4), 2301–2314. https://doi.org/10.1021/acs.cgd.0c01707
Kumar, A., & Nanda, A. (2021). In-silico methods of cocrystal screening: A review on tools for rational design of pharmaceutical cocrystals. In Journal of Drug Delivery Science and Technology (Vol. 63). Editions de Sante. https://doi.org/10.1016/j.jddst.2021.102527
Li, D., Kong, M., Li, J., Deng, Z., & Zhang, H. (2018). Amine-carboxylate supramolecular synthon in pharmaceutical cocrystals. CrystEngComm, 20(35), 5112–5118. https://doi.org/10.1039/C8CE01106K
Liu, Y., Li, S., Xu, J., Zhang, H., Guan, Y., Jiang, H., Huang, S., Huang, H., & Wang, Z. (2018). Three Energetic 2,2′,4,4′,6,6′-Hexanitrostilbene Cocrystals Regularly Constructed by H-bonding, π-Stacking, and van der Waals Interactions. Crystal Growth and Design, 18(4), 1940–1943. https://doi.org/10.1021/acs.cgd.8b00019
Mangesh, B., Sumedh, P., Sumedh, M., & Pradhan, B. (2019). Scientific Coformer Screening, Preparation and Evaluation of Fenofibrate Tartaric Acid Cocrystal. Journal of Drug Delivery and Therapeutics, 9(4), 406–410. https://doi.org/10.22270/jddt.v9i4.3199
Mohammad, M. A., Alhalaweh, A., & Velaga, S. P. (2011). Hansen solubility parameter as a tool to predict cocrystal formation. International Journal of Pharmaceutics, 407(1–2), 63–71. https://doi.org/10.1016/j.ijpharm.2011.01.030
Musumeci, D., Hunter, C. A., Prohens, R., Scuderi, S., & McCabe, J. F. (2011). Virtual cocrystal screening. Chemical Science, 2(5), 883–890. https://doi.org/10.1039/c0sc00555j
Nurhikmah, W., Sumirtapura, Y. C., & Pamudji, J. S. (2016). Dissolution profile of mefenamic acid solid dosage forms in two compendial and biorelevant (FaSSIF) media. Scientia Pharmaceutica, 84(1), 181–190. https://doi.org/10.3797/scipharm.ISP.2015.09
Putra, O. D., Umeda, D., Fujita, E., Haraguchi, T., Uchida, T., Yonemochi, E., & Uekusa, H. (2018). Solubility improvement of benexate through salt formation using artificial sweetener. Pharmaceutics, 10(2). https://doi.org/10.3390/pharmaceutics10020064
Saha, S., & Desiraju, G. R. (2018). Acid⋯Amide Supramolecular Synthon in Cocrystals: From Spectroscopic Detection to Property Engineering. Journal of the American Chemical Society, 140(20), 6361–6373. https://doi.org/10.1021/jacs.8b02435
Sarcevica, I., Orola, L., Belyakov, S., & Veidis, M. V. (2013). Spontaneous cocrystal hydrate formation in the solid state: Crystal structure aspects and kinetics. New Journal of Chemistry, 37(10), 2978–2982. https://doi.org/10.1039/c3nj00489a
Singh, M., Barua, H., Jyothi, V. G. S. S., Dhondale, M. R., Nambiar, A. G., Agrawal, A. K., Kumar, P., Shastri, N. R., & Kumar, D. (2023). Cocrystals by Design: A Rational Coformer Selection Approach for Tackling the API Problems. In Pharmaceutics (Vol. 15, Issue 4). MDPI. https://doi.org/10.3390/pharmaceutics15041161
Siswandi, S., Rusdiana, T., & Levita, J. (2015). Virtual screening of co-formers for ketoprofen co-crystallization and the molecular properties of the co-crystal. Journal of Applied Pharmaceutical Science, 5(6), 078–082. https://doi.org/10.7324/JAPS.2015.50613
Tahir, M. N., Ashfaq, M., de la Torre, A. F., Caballero, J., Hernández-Rodríguez, E. W., & Ali, A. (2019). Rationalizing the stability and interactions of 2,4-diamino-5-(4-chlorophenyl)-6-ethylpyrimidin-1-ium 2-hydroxy-3,5-dinitrobenzoate salt. Journal of Molecular Structure, 1193, 185–194. https://doi.org/10.1016/j.molstruc.2019.05.003
Taylor, C. R., & Day, G. M. (2018). Evaluating the Energetic Driving Force for Cocrystal Formation. Crystal Growth and Design, 18(2), 892–904. https://doi.org/10.1021/acs.cgd.7b01375
Utami, D. W. I., Nugrahani, I., & Ibrahim, S. (2017). Mefenamic acid-nicotinamide co-crystal synthesized by using melt crystallization method and its solubility study. Asian Journal of Pharmaceutical and Clinical Research, 10(5), 135–139. https://doi.org/10.22159/ajpcr.2017.v10i5.15863
Vener, M. V., Levina, E. O., Koloskov, O. A., Rykounov, A. A., Voronin, A. P., & Tsirelson, V. G. (2014). Evaluation of the lattice energy of the two-component molecular crystals using solid-state density functional theory. Crystal Growth and Design, 14(10), 4997–5003. https://doi.org/10.1021/cg5005243
Wouters, J., Rome, S., & Quéré, L. (2011). Monographs of most Frequent Co-Crystal Formers. In J. Wouters & L. Quéré (Eds.), Pharmaceutical Salts and Co-crystals (p. 0). The Royal Society of Chemistry. https://doi.org/10.1039/9781849733502-00338
Zhang, H., Sun, S., Wang, Y., & Cao, J. (2017). Interaction of sucralose with whey protein: Experimental and molecular modeling studies. Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 187, 92–97. https://doi.org/10.1016/j.saa.2017.06.030
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 JURNAL INFO KESEHATAN
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright notice
Ownership of copyright
The copyright in this website and the material on this website (including without limitation the text, computer code, artwork, photographs, images, music, audio material, video material and audio-visual material on this website) is owned by JURNAL INFO KESEHATAN and its licensors.
Copyright license
JURNAL INFO KESEHATAN grants to you a worldwide non-exclusive royalty-free revocable license to:
- view this website and the material on this website on a computer or mobile device via a web browser;
- copy and store this website and the material on this website in your web browser cache memory; and
- print pages from this website for your use.
- All articles published by JURNAL INFO KESEHATAN are licensed under the Creative Commons Attribution 4.0 International License. This permits anyone to copy, redistribute, remix, transmit and adapt the work provided the original work and source is appropriately cited.
JURNAL INFO KESEHATAN does not grant you any other rights in relation to this website or the material on this website. In other words, all other rights are reserved.
For the avoidance of doubt, you must not adapt, edit, change, transform, publish, republish, distribute, redistribute, broadcast, rebroadcast or show or play in public this website or the material on this website (in any form or media) without appropriately and conspicuously citing the original work and source or JURNAL INFO KESEHATAN prior written permission.
Permissions
You may request permission to use the copyright materials on this website by writing to jurnalinfokesehatan@gmail.com.
Enforcement of copyright
JURNAL INFO KESEHATAN takes the protection of its copyright very seriously.
If JURNAL INFO KESEHATAN discovers that you have used its copyright materials in contravention of the license above, JURNAL INFO KESEHATAN may bring legal proceedings against you seeking monetary damages and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of JURNAL INFO KESEHATAN copyright materials that contravenes or may contravene the license above, please report this by email to jurnalinfokesehatan@gmail.com
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to jurnalinfokesehatan@gmail.com.
